We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.7B
1-Year Est. Return 173.77%
This Fund
S&P 500
This Quarter Est. Return
+11.25%
1 Year Est. Return
+173.77%
3 Year Est. Return
+266.65%
5 Year Est. Return
+530.55%
10 Year Est. Return
+2,805.24%
AUM
$3.22B
AUM Growth
-$72.5M
Cap. Flow
-$496M
Cap. Flow %
-15.42%
Top 10 Hldgs %
76.64%
Holding
93
New
9
Increased
14
Reduced
27
Closed
16

Top Buys

Rank Stock Value
1
AGN.PRA
Allergan plc
AGN.PRA
+$41.4M
2
IBB icon
iShares Biotechnology ETF
IBB
+$28.7M
3
TWX
Time Warner Inc
TWX
+$15.6M
4
BFH icon
Bread Financial
BFH
+$10.6M
5
CALM icon
Cal-Maine
CALM
+$10.2M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$17.7M
2
MRVL icon
Marvell Technology
MRVL
+$11M
3
TSLA icon
Tesla
TSLA
+$9.56M
4
IMAX icon
IMAX
IMAX
+$7.62M
5
JOYY
JOYY Inc
JOYY
+$7.52M

Sector Composition

Rank Sector Weight
1 Healthcare 55.59%
2 Miscellaneous 31.87%
3 Consumer Discretionary 3.25%
4 Communication Services 2.67%
5 Financials 2.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIOX
1
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1.12B 34.8%
9,375,000
– –
MYOV
2
DELISTED
Myovant Sciences Ltd.
MYOV
$437M 13.57%
37,231,342
– –
XBI icon
3
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.4B
$404M 12.55%
5,829,700
-3,076,700
-35% -$207M
MMYT icon
4
MakeMyTrip
MMYT
$5.04B
$69M 2.14%
2,053,014
-167,905
-8% -$5.39M
IBB icon
5
iShares Biotechnology ETF
IBB
$10.5B
$68.1M 2.11%
696,435
+300,000
+76% +$28.7M
ABUS icon
6
Arbutus Biopharma
ABUS
$1.03B
$52M 1.62%
16,013,540
– –
AGN.PRA
7
DELISTED
Allergan plc
AGN.PRA
$42.4M 1.32%
+50,000
New +$41.4M
NYT icon
8
New York Times
NYT
$10.9B
$26.6M 0.83%
1,846,822
-102,330
-5% -$1.46M
KMX icon
9
CarMax
KMX
$8.65B
$24.3M 0.75%
410,089
+82,800
+25% +$5.38M
KANG
10
DELISTED
iKang Healthcare Group, Inc.
KANG
$22.8M 0.71%
1,560,843
+159,203
+11% +$2.62M
INTC icon
11
Intel
INTC
$555B
$21.2M 0.66%
587,314
-489,890
-45% -$17.7M
BFH icon
12
Bread Financial
BFH
$4.16B
$21.1M 0.66%
106,211
+55,932
+111% +$10.6M
GS icon
13
Goldman Sachs
GS
$301B
$18.8M 0.58%
81,940
+4,002
+5% +$966K
NRE
14
DELISTED
NorthStar Realty Europe Corp.
NRE
$18.8M 0.58%
1,664,363
-428,138
-20% -$5.18M
PYPL icon
15
PayPal
PYPL
$45.6B
$17.3M 0.54%
402,573
+7,771
+2% +$325K
EQC
16
DELISTED
Equity Commonwealth
EQC
$17.3M 0.54%
554,688
-65,075
-10% -$2.02M
ATEX icon
17
Anterix
ATEX
$1.67B
$16.9M 0.53%
894,031
– –
AVXS
18
DELISTED
AveXis, Inc. Common Stock
AVXS
$16.8M 0.52%
220,356
-4,400
-2% -$272K
SBGI icon
19
Sinclair Inc
SBGI
$995M
$16.1M 0.5%
397,023
+82,558
+26% +$3.04M
TWX
20
DELISTED
Time Warner Inc
TWX
$15.8M 0.49%
+161,518
New +$15.6M
AMBA icon
21
Ambarella
AMBA
$2.84B
$15.7M 0.49%
287,577
-35,500
-11% -$1.92M
ASMB icon
22
Assembly Biosciences
ASMB
$723M
$15.6M 0.49%
57,901
-8,065
-12% -$1.98M
AGEN
23
Agenus
AGEN
$341M
$15.5M 0.48%
208,820
+151
+0.1% +$12K
CTRA
24
DELISTED
Coterra Energy
CTRA
$13M 0.4%
544,142
-280,600
-34% -$6.37M
XLRN
25
DELISTED
Acceleron Pharma
XLRN
$12.7M 0.39%
480,437
-19,900
-4% -$524K
1
2 3 4

Similar funds

AHT
Amanah Holdings Trust London $1.7B AUM 612.53% 1-Year Est. Return
ARAM
Ardmore Road Asset Management New York $1.7B AUM 50.85% 1-Year Est. Return
GC
Gillson Capital Chicago, Illinois $1.7B AUM 16.09% 1-Year Est. Return
TWP
Triad Wealth Partners Lawrence, Kansas $1.7B AUM 21.07% 1-Year Est. Return
FBB
Fulton Breakefield Broenniman Bethesda, Maryland $1.7B AUM 23.97% 1-Year Est. Return
GD
Galaxy Digital New York $1.7B AUM
SG
Sienna Gestion Paris, France $1.71B AUM 43.66% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.71B AUM 0.89% 1-Year Est. Return

QVT Financial's Q1 2017 Portfolio in Review

As of Q1 2017, QVT Financial held 93 positions worth $3.22B, down 2.2% from $3.29B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

QVT Financial withdrew a net $496M in Q1 2017, closing 16 positions and reducing 27 holdings. Its most notable exit was Marvell Technology, an estimated $11M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 49% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

Against the trend, QVT Financial opened a new position in Allergan plc worth $42.4M.

  • QVT Financial's largest Q1 2017 buy was Allergan plc: 50,000 shares worth $42.4M.
  • QVT Financial added most to iShares Biotechnology ETF in Q1 2017, an estimated $28.7M increase.
  • QVT Financial's biggest Q1 2017 reduction was Intel, cutting an estimated $17.7M.
  • QVT Financial fully exited Marvell Technology in Q1 2017, selling an estimated $11M.
  • QVT Financial's ten largest holdings make up 77% of its $3.22B portfolio in Q1 2017.
  • QVT Financial opened 9 new positions and closed 16 in Q1 2017.
  • QVT Financial's portfolio value fell 2.2% quarter-over-quarter to $3.22B.

Based on QVT Financial's 13F filing for Q1 2017, filed 15 May 2017.